Brief and Event Examine Racial Disparities
in Cancer Outcomes, Care, and Treatment
Cancer has historically
been the second leading cause of death for people in the United States
except for periods during the pandemic when there were surges of
COVID-related deaths. While cancer occurrences and deaths have declined
for all racial and ethnic groups, a new KFF brief
reports that Black people remain at increased risk of cancer death
compared to White people, despite having comparable rates of new cancers
and some types of cancer screening. The higher mortality rate among Black
people partly reflects a later stage of disease at diagnosis among Black
patients, although Black patients additionally have lower stage-specific
survival for most cancer types.
Findings from the new
issue brief, Racial
Disparities in Cancer Outcomes, Screening, and Treatment,
were released today at a briefing
co-hosted with the American Society of Clinical Oncology examining
persistent racial disparities in cancer care and discussing a range of
actions at the patient-provider, health system, and policy level to achieve equity in care and
outcomes. A panel featuring oncologists, a patient advocate, and policy
researchers discussed clinical trial participation by underrepresented
populations, cancer screening guidelines for specific demographic groups,
and how inequities in socioeconomic factors and other determinants of
health and bias among medical providers contribute to disparities.
|
.png?width=1200&upscale=true&name=Just%20Released%20Header_1%20(1).png)
No comments:
Post a Comment